Month: March 2026

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce that, effective at the close of markets on March 20, 2026, the Company has been included in the VanEck Junior Gold Miners (“GDXJ”) exchange-traded fund (“ETF”), pursuant to the GDXJ quarterly rebalance. The GDXJ is an ETF that tracks an index of small- and mid-cap companies primarily involved in precious metals mining, providing retail investors indirect exposure to precious metals through junior and mid-tier mining equities. CEO Shane Williams is thrilled with the inclusion and has stated, “We are pleased to be included in the widely followed GDXJ index, which we believe will further elevate our market visibility and trading liquidity profile...

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 383,346 932.90 357,623,64816 March 2026 16,448 876.13 14,410,51917 March 2026 16,637 884.52 14,715,74318 March 2026 16,892 872.06 14,730,91519...

EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that it will report Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026. Presented by CEO Dave Marver, the webcast will be held at 2:00 p.m. CEST / 08:00 a.m. ET. To join the session, please register using this link. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities. Building on decades of scientific discovery,...

STMicroelectronics China-manufactured STM32 microcontrollers begin volume productionFirst deliveries of fully made-in-China STM32 microcontrollers to China-based customers are ongoing Localization of STM32 MCU manufacturing starts with high-performance STM32H7 series and will continue with performance-oriented, secure STM32H5 series and new entry-level STM32C5 seriesMarch 23, 2026, China​ – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announces the start of general-purpose STM32 microcontroller deliveries manufactured in China. The first batch of STM32 wafers fully produced in China by Huahong for ST is now being delivered to customers in China. This milestone is a major step forward in ST global supply chain strategy, with additional STM32 families,...

Pursuant to Article 241-2 of the General Regulations of the French Financial Markets Authority (Autorité des marchés financiers – the “AMF”), this description details the objectives and terms of the share buyback program of OVH Groupe, which the Board of Directors has decided to implement on the basis of the 17th resolution of the General Shareholders’ Meeting of February 12, 2026. The share buyback program described in this document relates to OVH Groupe shares admitted to trading on the Euronext Paris regulated market under ISIN code FR0014005HJ9 (Ticker: OVH). In accordance with the provisions of Article 241-2 II of the AMF’s General Regulations, during the implementation of the buyback program, any modification to any of the information set out in this description must be disclosed to the public as soon as possible in accordance...

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, March 23, 2026 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) reported today on recent public comments by political leaders and observers in Quebec regarding the province’s energy security and the potential role of local natural gas development as well as a notice from the Government. Following the completion of the corporate reorganization in January 2026, the economic rights to the Quebec assets are held by the Series 2 Preferred shareholders of the Company. Michael Binnion, President and Chief Executive Officer of Questerre, commented, “We welcome recent comments and public debate regarding Quebec’s strategic autonomy in energy,...

Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today the dosing of the first healthy volunteer in the first-in-human phase 1 study of BAL2420, evaluating the safety, tolerability and pharmacokinetics of this lipopolysaccharide transport protein A (LptA) inhibitor. BAL2420 belongs to a novel class of antibiotics. It targets LptA, which is part of the lipopolysaccharide transport bridge, an essential structure in Gram-negative bacteria. LptA inhibitors have shown potent and rapid bactericidal activity in vitro and in vivo against Gram-negative bacteria of the Enterobacteriaceae family, such as E. coli and K. pneumoniae, including strains resistant to beta-lactams...